{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:36:04Z","timestamp":1780360564343,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cpet.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T12:53:33Z","timestamp":1719060813000},"page":"561-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lymphoma"],"prefix":"10.1016","volume":"19","author":[{"given":"St\u00e9phane","family":"Chauvie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Castellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Bergesio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"De Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rexhep","family":"Durmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.cpet.2024.05.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"27","key":"10.1016\/j.cpet.2024.05.009_bib2","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and Non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2024.05.009_bib3","first-page":"946","article-title":"Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010","volume":"99","author":"Ardeshna","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2024.05.009_bib4","first-page":"2124","article-title":"The strategies to Homogenize PET\/CT metrics: the case of onco-haematological clinical trials","volume":"4","author":"Chauvie","year":"2016","journal-title":"Biomedicine"},{"key":"10.1016\/j.cpet.2024.05.009_bib5","article-title":"Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose\/Positron Emission Tomography in advanced Hodgkin lymphoma","author":"Biggi","year":"2017","journal-title":"Q\u00a0J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2024.05.009_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ejmp.2016.04.004","article-title":"The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)","volume":"32","author":"Chauvie","year":"2016","journal-title":"Phys Med"},{"issue":"3","key":"10.1016\/j.cpet.2024.05.009_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpet.2019.03.002","article-title":"PET-derived quantitative metrics for response and prognosis in lymphoma","volume":"14","author":"Kostakoglu","year":"2019","journal-title":"Pet Clin"},{"issue":"9","key":"10.1016\/j.cpet.2024.05.009_bib8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41571-023-00799-2","article-title":"Quantitative PET-based biomarkers in lymphoma: getting ready for primetime","volume":"20","author":"Alderuccio","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2024.05.009_bib9","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.278663","article-title":"Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study","volume":"107","author":"Kostakoglu","year":"2022","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.cpet.2024.05.009_bib10","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2020001900","article-title":"High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma","volume":"4","author":"Dean","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.cpet.2024.05.009_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-021-04560-6","article-title":"Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy","volume":"100","author":"Iacoboni","year":"2021","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.cpet.2024.05.009_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.annonc.2023.10.121","article-title":"Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial","volume":"35","author":"Cottereau","year":"2023","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2024.05.009_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/bloodadvances.2017015164","article-title":"Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma","volume":"2","author":"Delfau-Larue","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.cpet.2024.05.009_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-022-09758-z","article-title":"Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma \u2013 data from the prospective, multicenter phase III HD16 trial","volume":"22","author":"van Heek","year":"2022","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cpet.2024.05.009_bib15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/bjh.18734","article-title":"Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: a Children\u2019s Oncology Group study","volume":"201","author":"Milgrom","year":"2023","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cpet.2024.05.009_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.semnuclmed.2017.09.005","article-title":"Metabolic tumor volume metrics in lymphoma","volume":"48","author":"Kostakoglu","year":"2017","journal-title":"Semin Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2024.05.009_bib17","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2967\/jnumed.119.227249","article-title":"Time to prepare for risk adaptation in lymphoma by standardizing measurement of metabolic tumor burden","volume":"60","author":"Barrington","year":"2019","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2024.05.009_bib18","first-page":"266322","article-title":"Tumor location relative to the spleen is a prognostic factor in lymphoma patients: a demonstration from the REMARC trial","volume":"123","author":"Girum","year":"2023","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2024.05.009_bib19","first-page":"229450","article-title":"18 F-FDG-PET dissemination features in diffuse large B cell lymphoma are prognostic of outcome","volume":"119","author":"Cottereau","year":"2019","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2024.05.009_bib20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.annonc.2020.11.019","article-title":"Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET\/CT","volume":"32","author":"Cottereau","year":"2021","journal-title":"Ann Oncol"},{"issue":"25","key":"10.1016\/j.cpet.2024.05.009_bib21","first-page":"3055","article-title":"Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma","volume":"141","author":"Eertink","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cpet.2024.05.009_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/hon.3025","article-title":"Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: a radio-genomic study","volume":"40","author":"Durmo","year":"2022","journal-title":"Hematol Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2024.05.009_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000861","article-title":"Risk factors of progression in low-tumor burden follicular lymphoma initially managed by watch and wait in the era of PET and rituximab","volume":"7","author":"Rodier","year":"2023","journal-title":"Hemasphere"},{"issue":"2","key":"10.1016\/j.cpet.2024.05.009_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.cpet.2024.05.009_bib25","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.cpet.2024.05.009_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22319-4","article-title":"Radiomics features differentiate between normal and tumoral high-fdg uptake","volume":"8","author":"Hsu","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.cpet.2024.05.009_bib27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1109\/JBHI.2013.2283658","article-title":"Computer-aided staging of lymphoma patients with FDG PET\/CT imaging based on textural information","volume":"18","author":"Lartizien","year":"2014","journal-title":"IEEE J Biomed Health Inform"},{"issue":"3","key":"10.1016\/j.cpet.2024.05.009_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12149-011-0562-3","article-title":"Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET\/CT","volume":"26","author":"Watabe","year":"2012","journal-title":"Ann Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2024.05.009_bib29","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1002\/mp.12349","article-title":"Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas","volume":"44","author":"Ben Bouallegue","year":"2017","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.cpet.2024.05.009_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood-2018-01-826958","article-title":"Metabolic heterogeneity on baseline 18FDG-PET\/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma","volume":"132","author":"Ceriani","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cpet.2024.05.009_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12149-018-1260-1","article-title":"18F-FDG PET\/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin\u2019s lymphoma as predictors of treatment outcome and survival","volume":"32","author":"Parvez","year":"2018","journal-title":"Ann Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2024.05.009_bib32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00259-017-3899-6","article-title":"Diagnostic and prognostic value of baseline FDG PET\/CT skeletal textural features in diffuse large B cell lymphoma","volume":"45","author":"Aide","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.cpet.2024.05.009_bib33","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s00259-018-4041-0","article-title":"Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET\/CT is an independent prognostic factor of diffuse large B-cell lymphoma","volume":"45","author":"Decazes","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2024.05.009_bib34","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/bloodadvances.2019001201","article-title":"SAKK38\/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model","volume":"4","author":"Ceriani","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.cpet.2024.05.009_bib35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hon.2805","article-title":"Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B-cell lymphoma: post-hoc analysis from the SAKK38\/07 clinical trial","volume":"38","author":"Zucca","year":"2020","journal-title":"Hematol Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2024.05.009_bib36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jha2.421","article-title":"A\u00a0prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYA","volume":"3","author":"Kostakoglu","year":"2022","journal-title":"eJHaem"},{"issue":"1","key":"10.1016\/j.cpet.2024.05.009_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37197-z","article-title":"A\u00a0PET radiomics model to predict refractory mediastinal Hodgkin lymphoma","volume":"9","author":"Milgrom","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.cpet.2024.05.009_bib38","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1097\/RLU.0000000000002732","article-title":"Prognostic value of pretreatment radiomic features of 18F-FDG PET in patients with Hodgkin lymphoma","volume":"44","author":"Lue","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2024.05.009_bib39","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.acra.2019.10.015","article-title":"Intratumor heterogeneity assessed by 18F-FDG PET\/CT predicts treatment response and survival outcomes in patients with Hodgkin lymphoma","volume":"27","author":"Lue","year":"2020","journal-title":"Acad Radiol"},{"issue":"5","key":"10.1016\/j.cpet.2024.05.009_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-021-05626-3","article-title":"Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F]FDG PET\/CT features","volume":"49","author":"de Jesus","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859824000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859824000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T22:05:04Z","timestamp":1724882704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859824000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1556859824000555"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2024.05.009","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoma","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}